Session

IBD (Posters)

RADIOLOGIC EVALUATION OF FILGOTINIB TREATMENT IN PERIANAL FISTULIZING CROHN’S DISEASE USING A NOVEL SCORING SYSTEM
RADIOLOGIC EVALUATION OF FILGOTINIB TREATMENT IN PERIANAL FISTULIZING CROHN’S DISEASE USING A NOVEL SCORING SYSTEM

IBD (Posters)  et al.

HIGH C-REACTIVE PROTEIN LEVEL OF ACUTE SEVERE ULCERATIVE COLITIS IS ASSOCIATED WITH RE-ADMISSION DUE TO AGGRAVATION OF ULCERATIVE COLITIS: A KASID MULTICENTER STUDY
HIGH C-REACTIVE PROTEIN LEVEL OF ACUTE SEVERE ULCERATIVE COLITIS IS ASSOCIATED WITH RE-ADMISSION DUE TO AGGRAVATION OF ULCERATIVE COLITIS: A KASID MULTICENTER STUDY

IBD (Posters)  et al.

COMBINATION THERAPY IS NOT ASSOCIATED WITH IMPROVED RATES OF CLINICAL OR ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH USTEKINUMAB OR VEDOLIZUMAB
COMBINATION THERAPY IS NOT ASSOCIATED WITH IMPROVED RATES OF CLINICAL OR ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH USTEKINUMAB OR VEDOLIZUMAB

IBD (Posters)  et al.

THE OVERLAP BETWEEN CANNABINOID AND NOCICEPTIN SIGNALING AND ITS ROLE IN INTESTINAL INFLAMMATION – A PILOT STUDY
THE OVERLAP BETWEEN CANNABINOID AND NOCICEPTIN SIGNALING AND ITS ROLE IN INTESTINAL INFLAMMATION – A PILOT STUDY

IBD (Posters)  et al.

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

IBD (Posters)  et al.

PREVALENCE AND CLINICAL FACTORS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
PREVALENCE AND CLINICAL FACTORS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

IBD (Posters)  et al.

IFN-GAMMA-TREATED MACROPHAGES INDUCE EMT THROUGH THE WNT PATHWAY: RELEVANCE IN CROHN´S DISEASE
IFN-GAMMA-TREATED MACROPHAGES INDUCE EMT THROUGH THE WNT PATHWAY: RELEVANCE IN CROHN´S DISEASE

IBD (Posters)  et al.

SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY
SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY

IBD (Posters)  et al.

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY
EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY

IBD (Posters)  et al.

DECODING THE TAXONOMIC AND FUNCTIONAL PROFILES OF MICROBIOTA IN INFLAMMATORY BOWEL DISEASES–A MULTI-OMICS APPROACH
DECODING THE TAXONOMIC AND FUNCTIONAL PROFILES OF MICROBIOTA IN INFLAMMATORY BOWEL DISEASES–A MULTI-OMICS APPROACH

IBD (Posters)  et al.

E- CONSULTS IN INFLAMMATORY BOWEL DISEASE (TELEIBD): FACILITATING COMMUNICATION BETWEEN SPECIALIZED AND PRIMARY CARE
E- CONSULTS IN INFLAMMATORY BOWEL DISEASE (TELEIBD): FACILITATING COMMUNICATION BETWEEN SPECIALIZED AND PRIMARY CARE

IBD (Posters)  et al.

PHENOTYPIC DIFFERENCES IN INFLAMMATORY BOWEL DISEASE BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA
PHENOTYPIC DIFFERENCES IN INFLAMMATORY BOWEL DISEASE BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA

IBD (Posters)  et al.

EFFECT OF A GLUTEN-FREE DIET ON THE DISEASES SEVERITY, QUALITY OF LIFE, AND INFLAMMATORY MARKERS AMONG PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: A TRIPLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
EFFECT OF A GLUTEN-FREE DIET ON THE DISEASES SEVERITY, QUALITY OF LIFE, AND INFLAMMATORY MARKERS AMONG PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: A TRIPLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL

IBD (Posters)  et al.

BOWEL URGENCY COMMUNICATION GAP BETWEEN HEALTH CARE PROFESSIONALS AND PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
BOWEL URGENCY COMMUNICATION GAP BETWEEN HEALTH CARE PROFESSIONALS AND PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

IBD (Posters)  et al.

THE IMPACT OF BOWEL URGENCY ON THE LIVES OF PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
THE IMPACT OF BOWEL URGENCY ON THE LIVES OF PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

IBD (Posters)  et al.

QUALITY CRITERIA IN SCREENING COLONOSCOPY FOR COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE
QUALITY CRITERIA IN SCREENING COLONOSCOPY FOR COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

SARCOPENIA AS A PREDICTIVE MARKER IN INFLAMMATORY BOWEL DISEASE
SARCOPENIA AS A PREDICTIVE MARKER IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

INDICATIONS, OUTCOMES AND OTHER ASPECTS RELATED TO THE USE OF THE ENDOSCOPIC CAPSULE IN THE PEDIATRIC AGE
INDICATIONS, OUTCOMES AND OTHER ASPECTS RELATED TO THE USE OF THE ENDOSCOPIC CAPSULE IN THE PEDIATRIC AGE

IBD (Posters)  et al.

ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

IBD (Posters)  et al.

EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY

IBD (Posters)  et al.

Item 361 - 380 / 612
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
19
20 21 22 23 24 25 26 27 28 29 30 31